Propranolol for Anxiety
Propranolol is not recommended as a routine treatment for anxiety disorders based on current evidence, though it may have limited utility for specific performance anxiety situations like stage fright.
Evidence Quality and Recommendations
The most recent and highest-quality systematic review and meta-analysis 1 from 2025 found no evidence for a beneficial effect of beta-blockers compared with either placebo or benzodiazepines in patients with social phobia or panic disorder (p ≥ 0.54 for all comparisons). This confirms an earlier 2016 systematic review 2 which concluded that "the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders."
Notably, the 2023 Japanese clinical practice guideline for social anxiety disorder 3 specifically deprecates propranolol based on negative evidence, listing it among treatments not recommended for social anxiety disorder.
Limited Clinical Context Where Propranolol May Be Considered
Performance Anxiety (Stage Fright)
- Indication: Propranolol may be useful for prevention of performance anxiety such as fear of speaking in public or specific social phobias when limited in number 4
- Dosing: 20-40 mg once, given 1-2 hours before the performance
- Mechanism: Blocks peripheral somatic symptoms (tremor, tachycardia, sweating) rather than treating underlying anxiety
Thyroid-Related Anxiety
Propranolol is indicated for symptomatic management of anxiety associated with hyperthyroidism, thyrotoxicosis, or Graves' disease, where it addresses both tachycardia and tremor while inhibiting peripheral T4 to T3 conversion 5
Dosing Considerations (When Used Off-Label)
- Starting dose: 20 mg once to three times daily
- Typical range: 80-320 mg daily in divided doses
- Performance anxiety: Single 20-40 mg dose 1-2 hours before event 7
- Duration: Clinical efficacy beyond 4 weeks remains undemonstrated 4
Absolute Contraindications
Per FDA labeling 8:
- Cardiogenic shock
- Sinus bradycardia and greater than first-degree heart block
- Bronchial asthma (critical - avoid in any patient with asthma or obstructive airway disease)
- Known hypersensitivity to propranolol
Additional Contraindications from Guidelines
Important Clinical Caveats
Side Effects to Monitor:
- Bradycardia and hypotension (dose-dependent; 25% bradycardia rate with 40 mg dose 7)
- Potential depression in predisposed patients 4
- Cognitive impairment (controversial) 4
- Hypoglycemia risk (particularly relevant in diabetics or those with irregular eating)
Why Propranolol Fails as Anxiolytic: The evidence suggests propranolol primarily addresses peripheral somatic symptoms of anxiety (tremor, palpitations) rather than the core psychological symptoms. This explains why it may help with performance anxiety (where physical symptoms are prominent and time-limited) but fails in chronic anxiety disorders where cognitive and emotional symptoms predominate.
Recommended Alternatives
For generalized anxiety disorders, social anxiety disorder, or panic disorder, SSRIs (escitalopram, sertraline, paroxetamine) or SNRIs (venlafaxine) are first-line treatments with robust evidence 3. Benzodiazepines remain appropriate for acute anxiety requiring sedation, despite dependence concerns 4.